Stay updated on Safety/Efficacy of VB10.NEO & NKTR-214 Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Safety/Efficacy of VB10.NEO & NKTR-214 Immunotherapy Clinical Trial page.

Latest updates to the Safety/Efficacy of VB10.NEO & NKTR-214 Immunotherapy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 added and revision: v3.4.3 removed in the Record History view. This is a versioning update and does not affect study data or page functionality.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed in the study record history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history shows an addition of Revision: v3.4.2 and deletions including a government-funding notice and Revision: v3.4.1, which are administrative updates to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check60 days agoChange DetectedAdded a site-wide funding-status notice and updated the page version to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check68 days agoChange DetectedThe updates add UI elements such as a glossary and color-coded change indicators (green for additions, red for deletions) along with revision notes (v3.4.0). No core trial information is changed.SummaryDifference1.0%

- Check82 days agoChange DetectedAn additional revision entry v3.3.4 was added to the study record's history, and the previous revision v3.3.3 was removed. This updates the revision log to reflect the most recent change to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety/Efficacy of VB10.NEO & NKTR-214 Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety/Efficacy of VB10.NEO & NKTR-214 Immunotherapy Clinical Trial page.